NASDAQ · MYCL

SSGA Active Trust State Street My2032 Corporate Bond ETF (MYCL)

$23.59−0.55%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$23.59▼ 6.02% in range
Sep 29, 2025Low $23.59 · High $25.32Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

SSGA Active Trust State Street My2032 Corporate Bond ETF closed at $23.59 on Sep 28, down 0.55%, within 0.0% of its 52-week closing low. Volume of 895 shares was 0.90× its 20-day average (close to normal).

Split-adjusted performance: -3.3% over one month, -3.9% over six months, -5.7% over one year.

Short interest was 2.3K shares at the Sep 15 settlement, up 3.4% from the prior report (1.9 days to cover).

Market cap$11.8M500.0K shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield4.69%$0.0923 last paid
52-week range23.59 – 25.32−6.9% from high
Volume8950.90× 20-day avg
Volatility · 60d4.4%Annualised
Short % of float—1.9 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −1.5%1M −3.3%3M −4.6%6M −3.9%YTD −5.6%1Y −5.7%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short2.3K+3.4% vs prior
Days to cover1.9Settled Sep 15
% of float—
Short vol. 10d40.6%of daily volume

News about SSGA Active Trust State Street My2032 Corporate Bond ETF

All news →

No recent articles focused on SSGA Active Trust State Street My2032 Corporate Bond ETF.

Quick answers

What is MYCL's market cap?
$11.79M, based on the Sep 28 close of $23.59.
Does SSGA Active Trust State Street My2032 Corporate Bond ETF pay a dividend?
Yes. The latest regular dividend was $0.0923 per share (ex-date Sep 1), an annualised yield of 4.69%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology